US BUSINESS NEWS - Peru Base Metals Miners' 4Q Earnings Seen Grim - Wall Street Journal US BUSINESS NEWS - Peru Base Metals Miners' 4Q Earnings Seen Grim - Wall Street Journal

Monday, January 26, 2009

US BUSINESS NEWS - Peru Base Metals Miners' 4Q Earnings Seen Grim - Wall Street Journal

LIMA (Dow Jones)--Peru's base metal miners are expected to have seen plummeting earnings in the last quarter of 2008, mirroring falling mineral prices, while precious metals prices helped keep earnings more stable for other producers. "It's going in Stock and Shares News

MEXICO CITY (Dow Jones)--After a promising start to trading on Monday, Mexico's peso changed course and was weaker against the dollar in afternoon trading. The currency was quoted in Mexico City at MXN14.0690 to the dollar around 1:30 p.m. EST, after in Stock and Shares News

NEW YORK (MarketWatch) -- Rohm & Haas Co. filed a lawsuit Monday against former suitor Dow Chemical Co., accusing the chemical giant of postponing the merger deal indefinitely so it will have time to restructure -- and not because it lacks funding in Stock and Shares News

SIOUX FALLS, South Dakota : Oil prices jumped above $48 a barrel Monday, riding the coattails of rising equity markets despite signs of a deepening recession. Light, sweet crude for March delivery jumped $1.69 to $48.16 on the New York Mercantile in Stock and Shares News

Caterpillar's massive job cuts are not the end of the bad economic news this morning. The Home Depot and Sprint also announced huge layoffs today as Sprint will cut 8000 employees and the Home Depot will slash 7000 jobs while exiting the Home Depot in Stock and Shares News

NEW YORK (Dow Jones)--The Dow Jones-AIG Commodity Index decreased 3.42% for the month of January, Dow Jones Indexes said Monday in a press release. The three leading performing indexes were tin, with gains of 15.49%, lead, up 11.59% and sugar, which in Stock and Shares News

WASHINGTON -- The Food and Drug Administration said it was conducting a safety review of the anticlotting drug Plavix, focusing on whether the drug is less effective in certain patients. The review was announced Monday in a so-called early in Stock and Shares News

No comments: